AIDS InfoNet Logo
This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

The Henry J. Kaiser Family Foundation
Site of the Week
November 2003

The Health Leader Award 2006
The Health Leader Award 2006

The HOPE Reward

Med411.com Medical Award

HealthAtoZ.com Featured Site Award

BuscaSalud.com

IBS Tales Hope Award

HealingWell.com Editor's Choice Award

Listed in Listed in Treasures of the Internet


AIDS InfoNet Logo.  The AIDS InfoNet - Reliable, Up-to-Date AIDS Treatment Information
International Association of Providers of AIDS Care
Reviewed March 10, 2013

Fact Sheet 444

Nelfinavir (Viracept)


WHAT IS NELFINAVIR?
WHO SHOULD TAKE NELFINAVIR?
WHAT ABOUT DRUG RESISTANCE?
HOW IS NELFINAVIR TAKEN?
WHAT ARE THE SIDE EFFECTS?
HOW DOES NELFINAVIR REACT WITH OTHER DRUGS?
 


WHAT IS NELFINAVIR?

Nelfinavir, also called Viracept, is a drug used as part of antiretroviral therapy (ART). It is manufactured by ViiV Healthcare. Nelfinavir is a protease inhibitor. These drugs prevent the protease enzyme from working. HIV protease acts like a chemical scissors. It cuts the raw material for HIV into specific pieces needed to build a new virus. Protease inhibitors “gum up” these scissors.

Nelfinavir also fights some types of cancer. It has been studied against breast cancer and anal cancer.

 


WHO SHOULD TAKE NELFINAVIR?

Nelfinavir was approved in 1997 as an antiretroviral drug (ARV) for people with HIV infection of any age. In 2007, a potentially dangerous impurity was found in several batches of nelfinavir. Nelfinavir was recalled by the European Medicines Agency.  However, this was reversed several months later. The FDA recommended that nelfinavir not be used by any pregnant woman or in children until new manufacturing standards were met.  These conditions were met in May 2008.  

In late September 2007, The European Medicines Agency recommended the lifting of the ban on nelfinavir. This may not take effect until early 2008.

There are no absolute rules about when to start ART. You and your health care provider should consider your CD4 cell count, your viral load, any symptoms you are having, and your attitude about taking ART. Fact Sheet 404 has more information about guidelines for the use of ART.

If you take nelfinavir with other ARVs, you can reduce your viral load to extremely low levels, and increase your CD4 cell counts. This should mean staying healthier longer.

 


WHAT ABOUT DRUG RESISTANCE?

Many new copies of HIV are mutations. They are slightly different from the original virus. Some mutations can keep multiplying even when you are taking an ARV. When this happens, the drug will stop working. This is called “developing resistance” to the drug. See Fact Sheet 126 for more information on resistance.

Sometimes, if your virus develops resistance to one drug, it will also have resistance to other ARVs. This is called “cross-resistance.”

Resistance can develop quickly. It is very important to take ARVs according to instructions, on schedule, and not to skip or reduce doses.

 


HOW IS NELFINAVIR TAKEN?

Nelfinavir is taken by mouth as a capsule. It should be taken with a meal or a light snack. The original dose was 750 milligrams (mg) three times a day. Using 250 mg capsules, this meant taking 3 capsules at a time.

Late in 1999, the FDA approved twice-daily dosing of nelfinavir at 1250 mg per dose. This meant taking 5 capsules at a time. In April 2003 the FDA approved a 625 mg tablet. This cut the pill count to 2 tablets, twice a day.

If you want to change how often you take nelfinavir, talk to your health care provider. Different doses are used in some combinations. Be sure you know how much nelfinavir your health care provider has prescribed for you, and when and how to take each dose.

Nelfinavir should be stored at room temperature and protected from moisture, freezing, or excessive heat.

 


WHAT ARE THE SIDE EFFECTS?

The most common side effects of nelfinavir are diarrhea, weakness, headache, nausea, and abdominal pain. None of these side effects seem to be very serious. The diarrhea in most cases can be controlled with over-the-counter medications.

 


HOW DOES NELFINAVIR REACT WITH OTHER DRUGS?

Nelfinavir can interact with other drugs or supplements that you are taking. These interactions can change the amount of each drug in your bloodstream and cause an under- or overdose. New interactions are being identified all the time.

Drugs to watch out for include other ARVs, drugs to treat tuberculosis (see fact sheet 518), for erectile dysfunction (such as Viagra), for heart rhythm (antiarrhythmics), and for migraine headaches. Interactions are also possible with several antihistamines (allergy medications), sedatives, drugs to lower cholesterol, and anti-fungal drugs. Make sure that your health care provider knows about ALL drugs and supplements you are taking.

If you are taking nelfinavir and ddI, you should take ddI one hour before or two hours after nelfinavir.

Nelfinavir decreases blood levels of Kaletra.and can affect levels of Warfarin, used to adjust blood clotting.

Taking nelfinavir with delavirdine increases blood levels of both drugs. Avoid this combination.

Nelfinavir decreases methadone levels.Watch for signs of excessive sedation if you take nelfinavir with buprenorphine.

Some birth control pills may not work if you are taking nelfinavir. Talk to your health care provider about how to prevent an unwanted pregnancy.

The herb St. John's Wort (See Fact Sheet 729) lowers the blood levels of some protease inhibitors. Do not take it with nelfinavir.

 


 


Back to Fact Sheet Categories



New Mexico AIDS Education and Training Center The University of New Mexico Health Sciences Center International Association of Providers of AIDS Care

 

The AIDS InfoNet is a project of the New Mexico AIDS Education and Training Center at the University of New Mexico Health Sciences Center,
and the International Association of Providers of AIDS Care.
webmaster@aidsinfonet.org

 

United States National Library of Medicine

Partially funded by the National Library of Medicine



Search Our Site
Newest Fact Sheets
Print This Fact Sheet
You can print this fact sheet on a single page in Microsoft Word (.doc) format or Adobe Acrobat (.pdf) format. Click on the links below to open the document in your browser and then print it.
 Adobe Acrobat PDF
 Microsoft Word

You can print directly from your browser using the link below. The printout will probably go onto a second page.
 Print Version (Web)

Monthly E-mail Updates

The InfoNet updates its Fact Sheets frequently. A listing of each month's changes is posted to several e-mail lists.

If you would like to receive this monthly update by personal e-mail, please provide your e-mail address below, and click on the "Submit" button.



Subscribe
Unsubscribe